miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating Treg cells and improves ovarian cancer immunotherapy.

Gao, Tian; Lin, Yong-Qing; Ye, Hai-Yan; Lin, Wu-Mei

Gao, Tian; Lin, Yong-Qing; Ye, Hai-Yan; Lin, Wu-Mei.

Afiliación

Gao T; Department of Gynecology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Lin YQ; Department of Gynecology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Ye HY; Department of Gynecology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Lin WM; Department of Gynecology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.

Neoplasma ; 70(6): 713-721, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37962863

Asunto(s)

Exosomas; Células Madre Mesenquimatosas; MicroARNs; Neoplasias Ováricas; Humanos; Femenino; Linfocitos T Reguladores; MicroARNs/genética; MicroARNs/metabolismo; Neoplasias Ováricas/terapia; Neoplasias Ováricas/metabolismo; Inmunoterapia; Células Madre Mesenquimatosas/metabolismo; Lactatos/metabolismo; Microambiente Tumoral

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / MicroARNs / Exosomas / Células Madre Mesenquimatosas Límite: Female / Humans Idioma: En Revista: Neoplasma Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Eslovaquia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google